A low-molecular synthetic interferon inducer that stimulates the formation of all types of interferons in the body (alpha, beta, gamma and lambda). The main producers of interferon in response to the introduction of Tyloron are intestinal epithelial cells, hepatocytes, T-lymphocytes, neutrophils and granulocytes. After oral administration, the maximum production of interferon is determined in the sequence of the intestine - liver - blood after 4-24 hours. Tyloron has immunomodulatory and antiviral effect.
According to experimental studies, after a single oral administration of tylorone in a dose equivalent to the maximum daily dose for a person, the maximum concentration in the lung tissue of interferon lambda is determined after 24 hours, interferon alpha - after 48 hours. Induction of interferon lambda in the lung tissue contributes to an increase in antiviral protection of the respiratory tract in influenza and other respiratory viral infections.
In human leukocytes induces the synthesis of interferon.Stimulates bone marrow stem cells, depending on the dose, enhances antibody formation, reduces the degree of immunosuppression, restores the ratio of T-suppressors and T-helpers. Effective against various viral infections, including against influenza viruses, other acute respiratory viral infections, hepatitis viruses and herpesviruses. The mechanism of antiviral action is associated with the inhibition of the translation of virus-specific proteins in infected cells, as a result of which the reproduction of viruses is suppressed.